StockNews.com Begins Coverage on Milestone Scientific (NYSE:MLSS)

StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS) in a report released on Tuesday. The firm issued a hold rating on the stock.

Milestone Scientific Price Performance

Shares of NYSE:MLSS opened at $0.92 on Tuesday. The business has a fifty day moving average price of $0.97 and a 200-day moving average price of $0.79. The company has a market capitalization of $70.76 million, a PE ratio of -9.16 and a beta of 1.08. Milestone Scientific has a 1-year low of $0.52 and a 1-year high of $1.10.

Milestone Scientific (NYSE:MLSS) last released its quarterly earnings data on Thursday, August 15th. The company reported ($0.02) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.01). Milestone Scientific had a negative net margin of 54.87% and a negative return on equity of 60.78%. The firm had revenue of $1.85 million for the quarter.

Insiders Place Their Bets

In other news, Director Leonard Osser sold 141,913 shares of the company’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $0.95, for a total transaction of $134,817.35. Following the transaction, the director now directly owns 4,602,506 shares of the company’s stock, valued at $4,372,380.70. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In the last quarter, insiders sold 143,122 shares of company stock valued at $136,026. Corporate insiders own 24.75% of the company’s stock.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.